Latvia - Import of Heparin for Therapeutic Use

Since 2014, Latvia Import of Heparin for Therapeutic Use rose 2.1% year on year. In 2019, the country was number 104 comparing other countries in Import of Heparin for Therapeutic Use with $42,728.1. Latvia is overtaken by Swaziland, which was number 103 at $44,845.86 and is followed by Bahamas at $41,796. France topped the ranking with $960,128,653.6 in 2019, a fall of 6.6% versus 2018. United States, Singapore and Germany respectively ranked number 2, 3 and 4 in this ranking. Belize recorded the best 5 years average growth at +183.7% per year, while Mauritania was the worst growing country at -81.7% per year.

Loading...

Date US Dollars
2019 42,728.10
2018 41,665.43
2017 61,819.68
2016 52,009.82
2015 40,360.63
Download all data from 1994 to 2019

How does Latvia rank in Import of Heparin for Therapeutic Use?

# 155 Countries US Dollars Last YoY 5‑years CAGR
1 #1
France
960,128,653.60 2019 -6.6 % -5.3 % View data
2 #2
United States
422,842,642.50 2019 +0.9 % +2.3 % View data
103 #103
Swaziland
44,845.86 2019 -2.5 % -18.7 % View data
104 #104
Latvia
42,728.10 2019 +2.5 % +2.1 % View data
105 #105
Bahamas
41,796.00 2015 +581.8 % -20.3 % View data
Compare all 155 countries

Go Top